Full text is available at the source.
Abstract
Early postoperative outcomes could differ based on prior use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) or tirzepatide.
- Cardiovascular and kidney outcomes may be influenced by prior GLP-1RA or tirzepatide treatment.
- The study focuses on early postoperative results following metabolic and bariatric surgery.
- Differences in outcomes could inform patient management strategies after surgery.
Simplified